Presentation is loading. Please wait.

Presentation is loading. Please wait.

Didier Lardinois, MD, Renate Rechsteiner, MD, R

Published bySusanne Bäcker Modified over 5 years ago

Similar presentations

Presentation on theme: "Didier Lardinois, MD, Renate Rechsteiner, MD, R"— Presentation transcript:

1 Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors 
Didier Lardinois, MD, Renate Rechsteiner, MD, R.Hubert Läng, MD, Matthias Gugger, MD, Daniel Betticher, MD, Christian von Briel, MD, Thorsten Krueger, MD, Hans-Beat Ris, MD  The Annals of Thoracic Surgery  Volume 69, Issue 5, Pages (May 2000) DOI: /S (00)

2 Fig 1 Histologic features of thymic tumors according to the Marino and Müller-Hermelink classification. (A) medullary tumor, (B) mixed tumors, (C) organoid tumor, (D) cortical tumor, (E) well-differentiated thymic carcinoma, and (F) endocrine carcinoma (hematoxylin and eosin, original magnification ×400). The Annals of Thoracic Surgery  , DOI: ( /S (00) )

3 Fig 2 Kaplan-Meier–generated overall survival curves of patients after complete resection of thymic tumors according to the (A) Masaoka staging and (B) Marino and Müller-Hermelink classification. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

4 Fig 3 Kaplan-Meier–generated disease-free survival curves of patients after complete resection of thymic tumors according to the (A) Masaoka staging and (B) Marino and Müller-Hermelink classification. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

Download ppt "Didier Lardinois, MD, Renate Rechsteiner, MD, R"

Similar presentations

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,

Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,
Desmoid tumor of the chest wall with pleural involvement

Desmoid tumor of the chest wall with pleural involvement
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Primary thymic carcinoma

Primary thymic carcinoma
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Impact of Lung Function Changes After Induction Radiochemotherapy on Resected T4 Non-Small Cell Lung Cancer Outcome  Jean Perentes, MD, PhD, Sabina Bopp,

Impact of Lung Function Changes After Induction Radiochemotherapy on Resected T4 Non-Small Cell Lung Cancer Outcome  Jean Perentes, MD, PhD, Sabina Bopp,
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,
Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,
Wickii T. Vigneswaran, MD, Diana Y

Wickii T. Vigneswaran, MD, Diana Y
Tumors of the esophagogastric junction

Tumors of the esophagogastric junction
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

Similar presentations

Ads by Google